OR WAIT null SECS
September 20, 2023
Collaboration aims to cut medication costs for patients with conditions ranging from high blood pressure to diabetes.
The program to facilitate engagement between HCPs, industry, and regulatory bodies.
Deal aims to provide diabetes treatment to patients across the continent.
September 19, 2023
SaaS’ branded platform expected to help grow manufacturer’s therapeutic development processes.
CDMO will continue to produce commercial antibody cancer drug substance, featuring a new $242 million agreement.
The draft guidance document discusses the development of labeling for proposed biosimilars and interchangeable biosimilars for submission under section 351(k) of the Public Health Service Act.
September 15, 2023
PBM transparency and data reporting requirements are likely to be part of a larger healthcare bill that Congress will work on this fall.
Protective case manufacturer hires James Curleigh, as company prepares to further innovation and expand.
September 14, 2023
Appointment comes amid resignation of Marie-France Tschudin from company executive committee.
Collaboration aims to expedite the transportation of cancer detection radiopharmaceuticals throughout Chile.